pravastatin has been researched along with cholestanol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kubo, M; Matsuzawa, Y; Miki, H; Nakamura, T; Takemura, K; Tarui, S | 1 |
Miettinen, TA; Vanhanen, HT | 1 |
Fujiyama, J; Kuriyama, M; Osame, M; Tokimura, Y; Utatsu, Y | 1 |
Clarenbach, JJ; Dotti, MT; Federico, A; Kelleher, JK; Lindenthal, B; von Bergmann, K | 1 |
Antikainen, M; Gylling, H; Hedman, M; Ketomäki, A; Miettinen, TA | 1 |
Fukumoto, Y; Miura, M; Nochioka, K; Shiba, N; Shimokawa, H; Tanaka, S; Zhulanqiqige, do E | 1 |
3 trial(s) available for pravastatin and cholestanol
Article | Year |
---|---|
Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination.
Topics: Absorption; Apolipoproteins; Cholestanol; Cholesterol; Double-Blind Method; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Pravastatin; Squalene; Sterols; Triglycerides | 1995 |
Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy.
Topics: Adolescent; Anticholesteremic Agents; Child; Cholestanol; Cholesterol; Desmosterol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Phytosterols; Pravastatin; Sitosterols; Triglycerides | 2006 |
Ezetimibe improves endothelial function and inhibits Rho-kinase activity associated with inhibition of cholesterol absorption in humans.
Topics: Adult; Anticholesteremic Agents; Azetidines; Cholestanol; Cholesterol; Cross-Sectional Studies; Endothelium, Vascular; Ezetimibe; Female; Gene Expression Regulation, Enzymologic; Humans; Intestinal Absorption; Leukocytes; Male; Pravastatin; rho-Associated Kinases; Up-Regulation | 2012 |
3 other study(ies) available for pravastatin and cholestanol
Article | Year |
---|---|
Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosis.
Topics: Adult; Anticholesteremic Agents; Bile Acids and Salts; Brain Diseases; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Muscular Diseases; Naphthalenes; Pravastatin; Tendons; Xanthomatosis | 1991 |
Treatment of cerebrotendinous xanthomatosis: effects of chenodeoxycholic acid, pravastatin, and combined use.
Topics: Adult; Apolipoproteins; Brain Diseases; Chenodeoxycholic Acid; Cholestanol; Cholesterol; Drug Therapy, Combination; Electrophysiology; Humans; Lipids; Lipoproteins; Male; Middle Aged; Muscular Diseases; Phytosterols; Pravastatin; Tendons; Xanthomatosis | 1994 |
Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
Topics: Adult; Bile; Bile Acids and Salts; Carbon Isotopes; Chenodeoxycholic Acid; Cholestanol; Cholestanols; Cholesterol; Female; Gas Chromatography-Mass Spectrometry; Humans; Isotope Labeling; Lanosterol; Male; Middle Aged; Pravastatin; Sterols; Xanthomatosis, Cerebrotendinous | 2005 |